Abstract
3-Acetyl-N-(4-bromophenyl)-4-(diethylamino)selenet-2(2H)-imine (5a), which is conveniently obtained from the formal [2+2] cycloaddition of 4-bromophenyl isoselenocyanate and 4-(diethylamino)-3-butyn-2-one, reacts with amines, alcohols, water, and thiophenol to give the corresponding 2-methylen-3-oxobutane selenoamides 7 in good yields via ring opening to the ketenimine 6 and subsequent addition of the nucleophile.
Keywords: Ketenimines, ring opening, selenet-2(2H)-imines, selenium heterocycles, selenoamides, X-ray crystallography
Letters in Organic Chemistry
Title: Reactions of 4-(Diethylamino)selenet-2(2H)-imine with Nucleophiles – Synthesis of 2-Methylen-3-oxobutane Selenoamides
Volume: 7 Issue: 4
Author(s): Plamen K. Atanassov, Anthony Linden and Heinz Heimgartner
Affiliation:
Keywords: Ketenimines, ring opening, selenet-2(2H)-imines, selenium heterocycles, selenoamides, X-ray crystallography
Abstract: 3-Acetyl-N-(4-bromophenyl)-4-(diethylamino)selenet-2(2H)-imine (5a), which is conveniently obtained from the formal [2+2] cycloaddition of 4-bromophenyl isoselenocyanate and 4-(diethylamino)-3-butyn-2-one, reacts with amines, alcohols, water, and thiophenol to give the corresponding 2-methylen-3-oxobutane selenoamides 7 in good yields via ring opening to the ketenimine 6 and subsequent addition of the nucleophile.
Export Options
About this article
Cite this article as:
K. Atanassov Plamen, Linden Anthony and Heimgartner Heinz, Reactions of 4-(Diethylamino)selenet-2(2H)-imine with Nucleophiles – Synthesis of 2-Methylen-3-oxobutane Selenoamides, Letters in Organic Chemistry 2010; 7 (4) . https://dx.doi.org/10.2174/157017810791130685
DOI https://dx.doi.org/10.2174/157017810791130685 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Immunomodulatory Properties of Thalidomide Analogs: Pomalidomide and Lenalidomide, Experimental and Therapeutic Applications
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Dietary Habits of Mongolian People, and Their Influence on Lifestyle-Related Diseases and Early Aging
Current Aging Science Glial Reaction in Parkinsons Diseases: Inflammatory Activation Signaling of Glia as a Potential Therapeutic Target
Current Signal Transduction Therapy Histone Deacetylase (HDAC) Inhibitors - emerging roles in neuronal memory, learning, synaptic plasticity and neural regeneration
Current Neuropharmacology Medical Implants as Delivery Platforms for Tissue Engineering and Regenerative Medicine Applications
Current Tissue Engineering (Discontinued) Influence of a Novel Inhibitor (UM8190) of Prolylcarboxypeptidase (PRCP) on Appetite and Thrombosis
Current Medicinal Chemistry Pituitary Stem Cells Drop Their Mask
Current Stem Cell Research & Therapy Polymers and Drug Delivery Systems
Current Drug Delivery Cyclodextrins as Promoters in Aqueous Organic Synthesis
Current Organic Chemistry Molecular, Cellular and Clinical Aspects of Intracerebral Hemorrhage: Are the Enemies Within?
Current Neuropharmacology Transcriptional Regulation of Inflammatory Genes Associated with Severe Asthma
Current Pharmaceutical Design Withdrawal Notice: Circulatory Cells as Tumortropic Carrier for Targetability Improvement
Current Drug Delivery A Link Between Chemical Structure and Biological Activity in Triterpenoids
Recent Patents on Anti-Cancer Drug Discovery Characterization and Antihypertensive Effect of the Complex of (-)-β- pinene in β-cyclodextrin
Current Pharmaceutical Biotechnology PET Measurements of cAMP-Mediated Phosphodiesterase-4 with (R)-[11C]Rolipram
Current Radiopharmaceuticals Cardiovascular Risk in Patients with Primary Hyperparathyroidism
Current Pharmaceutical Design Conjugates of Natural Compounds with Nitroxyl Radicals as a Basis for Creation of Pharmacological Agents of New Generation
Current Medicinal Chemistry Cardiovascular Risk and Endothelial Dysfunction: The Preferential Route for Atherosclerosis
Current Pharmaceutical Biotechnology Experimental Fracture Protocols in Assessments of Potential Agents for Osteoporotic Fracture Healing Using Rodent Models
Current Drug Targets Non-Invasive Imaging of Ferucarbotran Labeled INS-1E Cells and Rodent Islets in Vitro and in Transplanted Diabetic Rats
Current Pharmaceutical Biotechnology